feed,title,long_url,short_url
🔐MarketWatch,Acrivon Therapeutics started at outperform with $25 stock price target at BMO Capital,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=ACRV&siteid=rss,https://da.gd/UEHJMr
